LONDON, Nov. 1 /PRNewswire/ -- Chiltern, a leading global clinical research organization, is pleased to announce that Diana Hatsis, R.N., B.S.N., C.O.T. will lecture at the JCAHPO annual continuing education program. Diana who designed an ophthalmic surgical instrument, the Hatsis LASIK Irrigation Cannula, worked in ophthalmic practice for several years prior to joining Chiltern as a Clinical Research Associate (CRA). The meeting will take place in New Orleans, Louisiana from November 9 - 13, 2007. The JCAHPO meetings will be located at the Hilton Riverside. Diana will be the lead instructor on three lectures, and co-instructing one of them with her brother, Dr. Alexander Hatsis, M.D., F.A.C.S. Dr. Hatsis was the first surgeon to perform refractive surgery with the Excimer laser on Long Island in 1995.
Monday, Nov. 12 from 11:30 am to 12:25 pm - Session 07M04
Wearing Many Hats: Managing Clinical Trials in an Ophthalmic Private
Tuesday, Nov, 13 from 10:20 am to 11:15 am - Session 04TU3
LASIK Complications (Lead Instructor: A. Hatsis, MD)
Tuesday, Nov, 13 from 11:30 am to 12:25 pm - Session 04TU4
Sands of the Sahara: A Refractive Emergency (co-instructor A. Hatsis, MD)
Tuesday, Nov, 13 from 1:50 pm to 2:45 pm - Session 07M06
Basic Surgical Assisting
"This will be my eighth year presenting at JCAHPO during AAO's annual meeting, it is always a great honor to be invited and a pleasure to teach and provide continuing education for health professionals in the field of ophthalmology," said Diana Hatsis. "My background in ophthalmology, eye surgeries, working in a private practice and now clinical research allows me to deliver courses with an insight in various aspects of the profession," Diana added.
"One of Chiltern's therapeutic expertise is ophthalmology and we have completed numerous trials, in various indications, in this area. Diana's expertise in the field of ophthalmology is well established and her passion about sharing her knowledge with others is reflected in the number of speaking engagements she has given over the years," said Kathy Zimmermann, Chiltern's Executive Director, Clinical Monitoring, Americas.
Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1100 people with 20 offices across the United States, United Kingdom, Germany, France, Italy, Spain, Poland, Czech Republic, Ukraine, India and South Africa. Chiltern provides services including Phase I and laboratory support, Global Clinical Development, Staff Resourcing, Biometrics, Regulatory and Medical Affairs.
For more information contact:
Chiltern International, Inc.
2111 Palomar Airport Road
Tel: 1 (760) 707 5025
Fax: 1 (760) 707 5022
|SOURCE Chiltern International, Inc.|
Copyright©2007 PR Newswire.
All rights reserved